Galen Partners and AIG Healthcare Partners has sold JDS Pharmaceuticals, a specialty pharmaceutical company, to Noven Pharmaceuticals for approximately $125 million cash at closing plus the assumption of approximately $10 million in net liabilities. www.noven.com
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.